{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:34:26Z","timestamp":1790620466076,"version":"4.1.0"},"reference-count":60,"publisher":"Bioscientifica","issue":"3","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is a complex yet common endocrine disorder, affecting 5\u201320% of reproductive-age women, characterised by a combination of hyperandrogenism, anovulation, and metabolic dysfunction. This combination of factors has traditionally been assumed to be the causative factors for the subfertility associated with PCOS, but significant microbial dysbiosis and alterations in immune function are identified in women with PCOS, suggesting a more complicated multifactorial impact on reproduction. Microbiome alterations vary between different PCOS subtypes, suggesting that hyperandrogenism and insulin resistance can impact microbial communities. The immunological implications of these microbiome changes are still poorly understood, along with their impact on reproductive outcomes, such as implantation, miscarriage, and assisted reproduction success rates. Although therapeutic interventions are chosen based on their endocrine and metabolic effects, many of these also target the microbiome and have immunomodulatory effects. Understanding these microbiome\u2013host interactions and immunological factors provides new insights into the complex spectrum of PCOS pathophysiology and provides the potential for novel therapeutic approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lay summary<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is a common hormonal condition affecting up to one in five women of reproductive age. It can cause irregular periods, excess hair growth, acne, and difficulties with fertility. Recent research suggests that PCOS not only is a hormonal disorder but also involves changes in the body\u2019s bacteria, known as the microbiome, and disturbances in the immune system. These changes may contribute to inflammation, insulin resistance, and hormone imbalance. Understanding how the microbiome and immune system interact in PCOS could lead to new ways to diagnose and treat the condition. Future therapies may focus on restoring a healthy microbiome to improve metabolic and reproductive health.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/raf-25-0187","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:05:23Z","timestamp":1782839123000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-13","source":"Crossref","is-referenced-by-count":1,"title":["Exploring emerging concepts in the pathophysiology of PCOS: microbiome dysbiosis and immunological dysregulation"],"prefix":"10.1530","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1295-1650","authenticated-orcid":true,"given":"Parijot","family":"Kumar","sequence":"first","affiliation":[{"name":"National Maternity Hospital 1 , ,","place":["Dublin, Ireland"]},{"name":"RCSI University of Medicine and Health Sciences 2 , ,","place":["Dublin, Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W","family":"O\u2019Reilly","sequence":"additional","affiliation":[{"name":"RCSI University of Medicine and Health Sciences 2 , ,","place":["Dublin, Ireland"]},{"name":"Beaumont Hospital 3 , ,","place":["Dublin, Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"McGowan","sequence":"additional","affiliation":[{"name":"Beaumont Hospital 3 , ,","place":["Dublin, Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6528-9704","authenticated-orcid":true,"given":"Conor","family":"Harrity","sequence":"additional","affiliation":[{"name":"RCSI University of Medicine and Health Sciences 2 , ,","place":["Dublin, Ireland"]},{"name":"Beaumont Hospital 3 , ,","place":["Dublin, Ireland"]},{"name":"Rotunda Hospital 4 , ,","place":["Dublin, Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"2026081110363172600_bib1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4049\/immunohorizons.2200033","article-title":"Immune dysfunction in polycystic ovary syndrome","volume":"7","author":"Banerjee","year":"2023","journal-title":"Immunohorizons"},{"key":"2026081110363172600_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.443","article-title":"Metabolic dysregulation and gut dysbiosis linked to hyperandrogenism in female mice","volume":"7","author":"Chen","year":"2024","journal-title":"Endocrinol Diabetes Metab"},{"key":"2026081110363172600_bib3","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3390\/diagnostics13061113","article-title":"Current guidelines for diagnosing PCOS","volume":"13","author":"Christ","year":"2023","journal-title":"Diagnostics"},{"key":"2026081110363172600_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112094","article-title":"Gut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus","volume":"142","author":"Duan","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"2026081110363172600_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"ESHRE\/ASRM","year":"2004","journal-title":"Fertil Steril"},{"key":"2026081110363172600_bib6","article-title":"Microbiome structure in healthy and pregnant women and importance of vaginal dysbiosis in spontaneous abortion","volume":"14","author":"Eslami","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"2026081110363172600_bib7","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.3390\/jcm13082278","article-title":"Vaginal microbiota and proinflammatory status in patients with polycystic ovary syndrome: an exploratory study","volume":"13","author":"Espinosa","year":"2024","journal-title":"J Clin Med"},{"key":"2026081110363172600_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.808508","article-title":"Gut and vaginal microbiomes in PCOS: implications for women\u2019s health","volume":"13","author":"Gu","year":"2022","journal-title":"Front Endocrinol"},{"key":"2026081110363172600_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13048-025-01638-x","article-title":"Enhancing understanding of endometrial function in patients with PCOS: clinical and immunological insights","volume":"18","author":"Guo","year":"2025","journal-title":"J Ovarian Res"},{"key":"2026081110363172600_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.711137","article-title":"The gut microbiome and sex hormone-related diseases","volume":"12","author":"He","year":"2021","journal-title":"Front Microbiol"},{"key":"2026081110363172600_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.662725","article-title":"Clinical manifestations of polycystic ovary syndrome and associations with the vaginal microbiome: a cross-sectional based exploratory study","volume":"12","author":"Hong","year":"2021","journal-title":"Front Endocrinol"},{"key":"2026081110363172600_bib12","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/rmb2.12389","article-title":"Analysis of vaginal and endometrial microbiota communities in infertile women with a history of repeated implantation failure","volume":"20","author":"Ichiyama","year":"2021","journal-title":"Reprod Med Biol"},{"key":"2026081110363172600_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/11786469221099214","article-title":"The kynurenine pathway and polycystic ovary syndrome: inflammation as a common denominator","volume":"15","author":"Jovanovic","year":"2022","journal-title":"Int J Tryptophan Res"},{"key":"2026081110363172600_bib14","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4103\/2230-8210.189231","article-title":"The inositols and polycystic ovary syndrome","volume":"20","author":"Kalra","year":"2016","journal-title":"Indian J Endocrinol Metab"},{"key":"2026081110363172600_bib15","doi-asserted-by":"crossref","first-page":"10636","DOI":"10.3390\/ijms251910636","article-title":"Impact of gut microbiota and SCFAs in the pathogenesis of PCOS and the effect of metformin therapy","volume":"25","author":"Kukaev","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026081110363172600_bib16","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/humrep\/deae270","article-title":"The reproductive tract microbiome in women with polycystic ovary syndrome and across different menstrual cycle phases","volume":"40","author":"Lee","year":"2025","journal-title":"Hum Reprod"},{"key":"2026081110363172600_bib17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s12275-024-00164-7","article-title":"The gut microbiota mediates the protective effects of spironolactone on myocardial infarction","volume":"62","author":"Li","year":"2024","journal-title":"J Microbiol"},{"key":"2026081110363172600_bib18","article-title":"Metabolic disorders in polycystic ovary syndrome: from gut microbiota biodiversity to clinical intervention","volume":"16","author":"Li","year":"2025","journal-title":"Front Endocrinol"},{"key":"2026081110363172600_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1209614","article-title":"The effects of N-acetylcysteine supplement on metabolic parameters in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"10","author":"Liu","year":"2023","journal-title":"Front Nutr"},{"key":"2026081110363172600_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.755741","article-title":"Changes in vaginal microbiome diversity in women with polycystic ovary syndrome","volume":"11","author":"Lu","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"2026081110363172600_bib21","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3390\/antiox10050759","article-title":"Coenzyme Q10 and immune function: an overview","volume":"10","author":"Mantle","year":"2021","journal-title":"Antioxidants"},{"key":"2026081110363172600_bib22","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.3390\/nu16223916","article-title":"Effectiveness of probiotics, prebiotics, and synbiotics in managing insulin resistance and hormonal imbalance in women with polycystic ovary syndrome (PCOS): a systematic review of randomized clinical trials","volume":"16","author":"Martinez Guevara","year":"2024","journal-title":"Nutrients"},{"key":"2026081110363172600_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1508893","article-title":"Gut microbiota: an emerging target connecting polycystic ovarian syndrome and insulin resistance","volume":"15","author":"Mei","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"2026081110363172600_bib24","first-page":"11","article-title":"A review on various uses of N-acetyl cysteine","volume":"19","author":"Mokhtari","year":"2017","journal-title":"Cell J"},{"key":"2026081110363172600_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.906258","article-title":"Microbial dysbiosis in the gut drives systemic autoimmune diseases","volume":"13","author":"Mousa","year":"2022","journal-title":"Front Immunol"},{"key":"2026081110363172600_bib26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.coemr.2020.03.004","article-title":"Polycystic ovary syndrome phenotypes and prevalence: differential impact of diagnostic criteria and clinical versus unselected population","volume":"12","author":"Mumusoglu","year":"2020","journal-title":"Curr Opin Endocr Metab Res"},{"key":"2026081110363172600_bib27","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.2147\/DDDT.S386974","article-title":"Coenzyme Q10 stimulate reproductive vatality","volume":"17","author":"Nie","year":"2023","journal-title":"Drug Des Devel Ther"},{"key":"2026081110363172600_bib28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5468\/ogs.21185","article-title":"A narrative review of the role of gastrointestinal dysbiosis in the pathogenesis of polycystic ovary syndrome","volume":"65","author":"Parker","year":"2022","journal-title":"Obstet Gynecol Sci"},{"key":"2026081110363172600_bib29","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41591-019-0509-0","article-title":"Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome","volume":"25","author":"Qi","year":"2019","journal-title":"Nat Med"},{"key":"2026081110363172600_bib30","article-title":"Intersection of polycystic ovary syndrome and the gut microbiome","volume":"5","author":"Rizk","year":"2020","journal-title":"J Endocr Soc"},{"key":"2026081110363172600_bib31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr Rev"},{"key":"2026081110363172600_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00394-017-1445-8","article-title":"Gut microbiota functions: metabolism of nutrients and other food components","volume":"57","author":"Rowland","year":"2018","journal-title":"Eur J Nutr"},{"key":"2026081110363172600_bib33","doi-asserted-by":"crossref","first-page":"8498","DOI":"10.1038\/s41467-024-52898-y","article-title":"Superior metabolic improvement of polycystic ovary syndrome traits after GLP1-based multi-agonist therapy","volume":"15","author":"S\u00e1nchez-Garrido","year":"2024","journal-title":"Nat Commun"},{"key":"2026081110363172600_bib34","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s12967-025-06315-7","article-title":"Gut microbiota: a hidden player in polycystic ovary syndrome","volume":"23","author":"Senthilkumar","year":"2025","journal-title":"J Transl Med"},{"key":"2026081110363172600_bib35","article-title":"The effectiveness of myo-inositol in women with polycystic ovary syndrome: a prospective clinical study","volume":"16","author":"Sharon","year":"2024","journal-title":"Cureus"},{"key":"2026081110363172600_bib36","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.3390\/jcm12041454","article-title":"Polycystic ovary syndrome: etiology, current management, and future therapeutics","volume":"12","author":"Singh","year":"2023","journal-title":"J Clin Med"},{"key":"2026081110363172600_bib37","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12088-022-01019-8","article-title":"Reshaping the gut microbiota through lifestyle interventions in women with PCOS: a review","volume":"62","author":"Sivasankari","year":"2022","journal-title":"Indian J Microbiol"},{"key":"2026081110363172600_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajum.12096","article-title":"Rotterdam criteria, the end","volume":"21","author":"Smet","year":"2018","journal-title":"Australas J Ultrasound Med"},{"key":"2026081110363172600_bib39","doi-asserted-by":"crossref","first-page":"10796","DOI":"10.3390\/ijms262110796","article-title":"Endometrial microbiome and reproductive receptivity: diverse perspectives","volume":"26","author":"Stoyancheva","year":"2025","journal-title":"Int J Mol Sci"},{"key":"2026081110363172600_bib40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13048-025-01621-6","article-title":"Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation","volume":"18","author":"Su","year":"2025","journal-title":"J Ovarian Res"},{"key":"2026081110363172600_bib41","article-title":"Gut microbiota dysbiosis in polycystic ovary syndrome: mechanisms of progression and clinical applications","volume":"13","author":"Sun","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"2026081110363172600_bib42","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/humrep\/dead156","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome\u2020","volume":"38","author":"Teede","year":"2023","journal-title":"Hum Reprod"},{"key":"2026081110363172600_bib43","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0140-6736(26)00717-8","article-title":"Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process","volume":"407","author":"Teede","year":"2026","journal-title":"Lancet"},{"key":"2026081110363172600_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/817849","article-title":"N-acetylcysteine for polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled clinical trials","volume":"2015","author":"Thakker","year":"2015","journal-title":"Obstet Gynecol Int"},{"key":"2026081110363172600_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202401772","article-title":"Androgens modulate the immune profile in a mouse model of polycystic ovary syndrome","volume":"11","author":"Torstensson","year":"2024","journal-title":"Adv Sci"},{"key":"2026081110363172600_bib46","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.3389\/fphys.2020.01108","article-title":"Comparative analysis of lower genital tract microbiome between PCOS and healthy women","volume":"11","author":"Tu","year":"2020","journal-title":"Front Physiol"},{"key":"2026081110363172600_bib47","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1530\/EC-17-0243","article-title":"Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials","volume":"6","author":"Unfer","year":"2017","journal-title":"Endocr Connect"},{"key":"2026081110363172600_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.endmts.2024.100159","article-title":"When one size does not fit all: reconsidering PCOS etiology, diagnosis, clinical subgroups, and subgroup-specific treatments","volume":"14","author":"Unfer","year":"2024","journal-title":"Endocr Metab Sci"},{"key":"2026081110363172600_bib49","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3390\/ijms27020759","article-title":"A systematic review on GLP-1 receptor agonists in reproductive health: integrating IVF data, ovarian physiology and molecular mechanisms","volume":"27","author":"Voros","year":"2026","journal-title":"Int J Mol Sci"},{"key":"2026081110363172600_bib50","article-title":"Dysregulation of immune response in PCOS organ system","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"2026081110363172600_bib51","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2147\/DMSO.S451129","article-title":"Effects of glucagon-like peptide-1 receptor agonists on gut microbiota in dehydroepiandrosterone-induced polycystic ovary syndrome mice: compared evaluation of liraglutide and semaglutide intervention","volume":"17","author":"Xiong","year":"2024","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2026081110363172600_bib52","article-title":"Metformin-mediated intestinal AMPK activation ameliorates PCOS through gut microbiota modulation and metabolic pathways","volume":"16","author":"Xu","year":"2025","journal-title":"Front Endocrinol"},{"key":"2026081110363172600_bib53","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqab118","article-title":"Intestinal flora is a key factor in insulin resistance and contributes to the development of polycystic ovary syndrome","volume":"162","author":"Yang","year":"2021","journal-title":"Endocrinology"},{"key":"2026081110363172600_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102884","article-title":"Gut microbiota in women with polycystic ovary syndrome: an individual based analysis of publicly available data","volume":"77","author":"Yang","year":"2024","journal-title":"EClinicalMedicine"},{"key":"2026081110363172600_bib55","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.gocm.2022.10.001","article-title":"Effects of immune cells and cytokines on the endometrial immune microenvironment in polycystic ovary syndrome","volume":"2","author":"Ye","year":"2022","journal-title":"Gynecol Obstet Clin Med"},{"key":"2026081110363172600_bib56","doi-asserted-by":"crossref","DOI":"10.1186\/s13048-025-01959-x","article-title":"Gut microbiota, a new approach to management of polycystic ovary syndrome: a systematic review, meta-analysis and meta-evidence of 26 randomized controlled trials","volume":"19","author":"Yin","year":"2026","journal-title":"J Ovarian Res"},{"key":"2026081110363172600_bib57","article-title":"The role of immunity in insulin resistance in patients with polycystic ovary syndrome","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Endocrinol"},{"key":"2026081110363172600_bib58","article-title":"Effects of vaginal microbiota on in vitro fertilization outcomes in women with different infertility causes","volume":"13","author":"Zhao","year":"2025","journal-title":"Microbiol Spectr"},{"key":"2026081110363172600_bib59","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18258","article-title":"Role of the gut microbiota and innate immunity in polycystic ovary syndrome: current updates and future prospects","volume":"28","author":"Zhou","year":"2024","journal-title":"J Cell Mol Med"},{"key":"2026081110363172600_bib60","doi-asserted-by":"crossref","first-page":"1659783","DOI":"10.3389\/fmicb.2025.1659783","article-title":"Gut microbiota dysbiosis in polycystic ovary syndrome: focus on diet, probiotics, and traditional Chinese medicine [review]","volume":"16","author":"Zhu","year":"2025","journal-title":"Front Microbiol"}],"container-title":["Reproduction and Fertility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/raf.bioscientifica.com\/view\/journals\/raf\/aop\/RAF-25-0187\/RAF-25-0187.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/raf.bioscientifica.com\/downloadpdf\/journals\/raf\/aop\/RAF-25-0187\/RAF-25-0187.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/raf\/article-pdf\/doi\/10.1530\/RAF-25-0187\/519718\/raf-25-0187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/raf\/article-pdf\/doi\/10.1530\/RAF-25-0187\/519718\/raf-25-0187.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:46:14Z","timestamp":1786463174000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/raf\/article\/7\/3\/RAF250187\/77525\/Exploring-emerging-concepts-in-the-pathophysiology"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1530\/raf-25-0187","relation":{},"ISSN":["2633-8386"],"issn-type":[{"value":"2633-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"article-number":"RAF250187"}}